FDA’s next headache for the dietary supplement market

The New York State Assembly is to amend its agriculture and markets law to require dietary and nutritional supplement manufacturers to label products as tested or untested by the Food and Drug Administration (FDA).

The New York State website maintains that some manufacturers choose to have their products tested by the FDA and others do not. It claims that the bill is intended to allow the consumer to know which products have been tested so that a more informed choice can be made when purchasing these various products. This bill deals only with the analysis of the product for purity; it does not deal with any medicinal attributes of the product.

But David Seckman, executive director/CEO of the Natural Products Association (NPA), was reported to comment that opposition to the bill would be mounted and that the association would lobby against it coming into law.

“It doesn’t make any sense,” said Seckman. “FDA doesn’t test products.”

Ultimately, bill number A2957, introduced on January 22, “provides that no person shall manufacture, sell or expose for sale any product which shall be termed as a dietary supplement or nutritional supplement without branding or labeling such product with a statement that the product has or has not been tested by the United States Food and Drug Administration,” the website continued.

To read the bill, a new subdivision 2 to S 214-m of the Agriculture and Markets Law, visit http://assembly.state.ny.us/leg/?bn=A02957&sh=t.

Originally published by nutraingredients-usa.com